Sacramento, CA, United States of America

Johnson Tran

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genzyme Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johnson Tran. Retrieved from https://idiyas.com/inventor/johnson-tran-p7ozp0k6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Johnson Tran in the Field of Medicine

Introduction

Johnson Tran is an accomplished inventor based in Sacramento, CA. He has made significant contributions to the medical field, particularly in the treatment of diseases through innovative methods. His work focuses on the detection and treatment of conditions such as Pompe disease.

Latest Patents

Johnson Tran holds a patent titled "Biomarkers of methotrexate-induced immune tolerance." This patent provides methods for treating diseases by detecting an erythropoiesis biomarker in a subject's sample after administering methotrexate and a therapeutic agent. The invention also includes methods and kits for assessing immune tolerance levels based on the detection of this biomarker.

Career Highlights

Tran's career is marked by his dedication to advancing medical treatments. He works at Genzyme Corporation, where he continues to develop innovative solutions for complex health issues. His expertise in the field has led to the creation of valuable patents that enhance patient care.

Collaborations

Johnson Tran collaborates with talented professionals, including Alexandra Joseph and Susan Richards. These partnerships foster a creative environment that drives innovation and improves research outcomes.

Conclusion

Johnson Tran's contributions to medical innovation through his patent on biomarkers demonstrate his commitment to improving treatment methods for diseases. His work at Genzyme Corporation and collaborations with colleagues further highlight his impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…